179 related articles for article (PubMed ID: 10615398)
1. Abnormal Ca2+ release from cardiac sarcoplasmic reticulum in tachycardia-induced heart failure.
Yamamoto T; Yano M; Kohno M; Hisaoka T; Ono K; Tanigawa T; Saiki Y; Hisamatsu Y; Ohkusa T; Matsuzaki M
Cardiovasc Res; 1999 Oct; 44(1):146-55. PubMed ID: 10615398
[TBL] [Abstract][Full Text] [Related]
2. Altered interaction of FKBP12.6 with ryanodine receptor as a cause of abnormal Ca(2+) release in heart failure.
Ono K; Yano M; Ohkusa T; Kohno M; Hisaoka T; Tanigawa T; Kobayashi S; Kohno M; Matsuzaki M
Cardiovasc Res; 2000 Nov; 48(2):323-31. PubMed ID: 11054478
[TBL] [Abstract][Full Text] [Related]
3. Polylysine-induced rapid Ca2+ release from cardiac sarcoplasmic reticulum.
Yano M; Yamamoto T; Kohno M; Hisaoka T; Ono K; Tanigawa T; Ueyama T; Ohkusa T; Matsuzaki M
J Cardiovasc Pharmacol; 1998 Jul; 32(1):96-100. PubMed ID: 9676727
[TBL] [Abstract][Full Text] [Related]
4. Effect of R56865 on cardiac sarcoplasmic reticulum function and its role as an antagonist of digoxin at the sarcoplasmic reticulum calcium release channel.
McGarry SJ; Scheufler E; Williams AJ
Br J Pharmacol; 1995 Jan; 114(1):231-7. PubMed ID: 7712023
[TBL] [Abstract][Full Text] [Related]
5. Propranolol prevents the development of heart failure by restoring FKBP12.6-mediated stabilization of ryanodine receptor.
Doi M; Yano M; Kobayashi S; Kohno M; Tokuhisa T; Okuda S; Suetsugu M; Hisamatsu Y; Ohkusa T; Kohno M; Matsuzaki M
Circulation; 2002 Mar; 105(11):1374-9. PubMed ID: 11901051
[TBL] [Abstract][Full Text] [Related]
6. Iron(II) is a modulator of ryanodine-sensitive calcium channels of cardiac muscle sarcoplasmic reticulum.
Kim E; Giri SN; Pessah IN
Toxicol Appl Pharmacol; 1995 Jan; 130(1):57-66. PubMed ID: 7530865
[TBL] [Abstract][Full Text] [Related]
7. Abnormal Ca2+ release, but normal ryanodine receptors, in canine and human heart failure.
Jiang MT; Lokuta AJ; Farrell EF; Wolff MR; Haworth RA; Valdivia HH
Circ Res; 2002 Nov; 91(11):1015-22. PubMed ID: 12456487
[TBL] [Abstract][Full Text] [Related]
8. FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure.
Yano M; Kobayashi S; Kohno M; Doi M; Tokuhisa T; Okuda S; Suetsugu M; Hisaoka T; Obayashi M; Ohkusa T; Kohno M; Matsuzaki M
Circulation; 2003 Jan; 107(3):477-84. PubMed ID: 12551874
[TBL] [Abstract][Full Text] [Related]
9. Dynamic changes in sarcoplasmic reticulum function in cardiac hypertrophy and failure.
Szymanska G; Strömer H; Kim DH; Lorell BH; Morgan JP
Pflugers Arch; 2000 Jan; 439(3):339-48. PubMed ID: 10650986
[TBL] [Abstract][Full Text] [Related]
10. Calcium-sensitivity of the SR calcium release channel in failing and nonfailing human myocardium.
Schotten U; Schumacher C; Conrads V; Braun V; Schöndube F; Voss M; Hanrath P
Basic Res Cardiol; 1999 Jun; 94(3):145-51. PubMed ID: 10424232
[TBL] [Abstract][Full Text] [Related]
11. Valsartan restores sarcoplasmic reticulum function with no appreciable effect on resting cardiac function in pacing-induced heart failure.
Okuda S; Yano M; Doi M; Oda T; Tokuhisa T; Kohno M; Kobayashi S; Yamamoto T; Ohkusa T; Matsuzaki M
Circulation; 2004 Feb; 109(7):911-9. PubMed ID: 14757694
[TBL] [Abstract][Full Text] [Related]
12. A new cardioprotective agent, JTV519, improves defective channel gating of ryanodine receptor in heart failure.
Kohno M; Yano M; Kobayashi S; Doi M; Oda T; Tokuhisa T; Okuda S; Ohkusa T; Kohno M; Matsuzaki M
Am J Physiol Heart Circ Physiol; 2003 Mar; 284(3):H1035-42. PubMed ID: 12433661
[TBL] [Abstract][Full Text] [Related]
13. The ryanodine binding sarcoplasmic reticulum calcium release channel in nonfailing and in failing human myocardium.
Schumacher C; Konigs B; Sigmund M; Kohne B; Schondube F; Vob M; Stein B; Weil J; Hanrath P
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 353(1):80-5. PubMed ID: 8750920
[TBL] [Abstract][Full Text] [Related]
14. Impairment of the ryanodine-sensitive calcium release channels in the cardiac sarcoplasmic reticulum and its underlying mechanism during the hypodynamic phase of sepsis.
Dong LW; Wu LL; Ji Y; Liu MS
Shock; 2001 Jul; 16(1):33-9. PubMed ID: 11442313
[TBL] [Abstract][Full Text] [Related]
15. Ryanodine binding to sarcoplasmic reticulum membrane; comparison between cardiac and skeletal muscle.
Michalak M; Dupraz P; Shoshan-Barmatz V
Biochim Biophys Acta; 1988 Apr; 939(3):587-94. PubMed ID: 3355834
[TBL] [Abstract][Full Text] [Related]
16. Identification of the Ca2+-release activity and ryanodine receptor in sarcoplasmic-reticulum membranes during cardiac myogenesis.
Michalak M
Biochem J; 1988 Aug; 253(3):631-6. PubMed ID: 2460083
[TBL] [Abstract][Full Text] [Related]
17. Correction of defective interdomain interaction within ryanodine receptor by antioxidant is a new therapeutic strategy against heart failure.
Yano M; Okuda S; Oda T; Tokuhisa T; Tateishi H; Mochizuki M; Noma T; Doi M; Kobayashi S; Yamamoto T; Ikeda Y; Ohkusa T; Ikemoto N; Matsuzaki M
Circulation; 2005 Dec; 112(23):3633-43. PubMed ID: 16330705
[TBL] [Abstract][Full Text] [Related]
18. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure.
Ai X; Curran JW; Shannon TR; Bers DM; Pogwizd SM
Circ Res; 2005 Dec; 97(12):1314-22. PubMed ID: 16269653
[TBL] [Abstract][Full Text] [Related]
19. Characterization of junctional and longitudinal sarcoplasmic reticulum from heart muscle.
Inui M; Wang S; Saito A; Fleischer S
J Biol Chem; 1988 Aug; 263(22):10843-50. PubMed ID: 2968985
[TBL] [Abstract][Full Text] [Related]
20. Effects of azumolene on doxorubicin-induced Ca2+ release from skeletal and cardiac muscle sarcoplasmic reticulum.
Tian Q; Katz AM; Kim DH
Biochim Biophys Acta; 1991 Aug; 1094(1):27-34. PubMed ID: 1883852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
